Bone Biologics Corp. Capital Expenditures

Capital Expenditures of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital Expenditures growth rates and interactive chart. Capital expenditures, commonly known as Capex, are funds used by a company to acquire, upgrade, and maintain physical or intangible assets such as property, buildings, an industrial plant, technology, software or equipment. Capex is often used to undertake new projects or investments by the firm. A company must invest over its lifetime into productive assets to maintain its competitiveness and ensure its survival.


Highlights and Quick Summary

  • Capital Expenditures for the quarter ending December 31, 2021 was $0 (a NaN% decrease compared to previous quarter)
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital Expenditures of Bone Biologics Corp.

Most recent Capital Expendituresof BBLG including historical data for past 10 years.

Interactive Chart of Capital Expenditures of Bone Biologics Corp.

Bone Biologics Corp. Capital Expenditures for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $0.0
2020 $0.0
2019 $0.0

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices